Form 4: CVS Director C. David Brown II Acquires Common Stock

CVS Health Director C. David Brown II acquired 1,544 shares of common stock as part of a semi-annual retainer payment.

Summary

• Director C. David Brown II acquired 1,544 shares of CVS Health common stock on May 14, 2026.
• The shares were issued at a price of $97.15 per share.
• The transaction represents payment for a semi-annual retainer under the 2017 Incentive Compensation Plan.
• Following this transaction, the director's total beneficial ownership is 129,316 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Director demonstrates alignment with shareholder interests through increased equity ownership.

Negatives

• None.

Risks

• None.

Future Outlook

Not applicable as this is a routine director compensation disclosure.

Industry Context

StockSavvy.ai notes that routine equity-based compensation for board members is standard practice among large-cap healthcare companies to ensure director interests remain aligned with long-term shareholder value.

Comparison to Industry Standards

• The issuance of stock in lieu of cash for director retainers is a common governance practice among S&P 500 companies to promote 'skin in the game'.
• The transaction size is consistent with standard non-executive director compensation packages for companies of CVS Health's market capitalization.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation-related transaction.

Next Steps

• None.

Key Dates

Keywords

CVS Health, Insider Trading, Form 4, Director Compensation, Equity Ownership